{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:21:30Z","timestamp":1790738490882,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clineuro.2021.106771","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T03:21:45Z","timestamp":1624332105000},"page":"106771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model"],"prefix":"10.1016","volume":"207","author":[{"given":"Leon","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-8132","authenticated-orcid":false,"given":"Alexander","family":"Perdomo-Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Casaos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-6817","authenticated-orcid":false,"given":"Sakibul","family":"Huq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-5953","authenticated-orcid":false,"given":"Iddo","family":"Paldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-9469","authenticated-orcid":false,"given":"Veronica","family":"Vigilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mangraviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-6969","authenticated-orcid":false,"given":"Betty","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106771_bib1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.clineuro.2021.106771_bib2","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2008.5.17557","article-title":"Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme","volume":"110","author":"McGirt","year":"2009","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2021.106771_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-015-1724-2","article-title":"Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis","volume":"122","author":"Chowdhary","year":"2015","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib5","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/nn504905q","article-title":"Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo","volume":"9","author":"Mangraviti","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.clineuro.2021.106771_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2018.12.048","article-title":"Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer","volume":"295","author":"Shapira-Furman","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.clineuro.2021.106771_bib7","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-18-3850","article-title":"Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste","volume":"25","author":"Smith","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.clineuro.2021.106771_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2014.00126","article-title":"Emerging insights into barriers to effective brain tumor therapeutics","volume":"4","author":"Woodworth","year":"2014","journal-title":"Front Oncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/02656736.2011.648137","article-title":"Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up","volume":"28","author":"Hijnen","year":"2012","journal-title":"Int J. Hyperth."},{"key":"10.1016\/j.clineuro.2021.106771_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.1928.02690380007003","article-title":"Removal of right cerebral hemisphere for certain tumors with hemiplegia \u2013 preliminary report","volume":"90","author":"Dandy","year":"1928","journal-title":"J. Am. Med Assoc."},{"key":"10.1016\/j.clineuro.2021.106771_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-004-2751-6","article-title":"Molecular mechanisms of glioma cell migration and invasion","volume":"70","author":"Demuth","year":"2004","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00157684","article-title":"Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo","volume":"14","author":"Sawaya","year":"1996","journal-title":"Clin. Exp. Metastas"},{"issue":"Pt 19","key":"10.1016\/j.clineuro.2021.106771_bib13","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1242\/jcs.110.19.2473","article-title":"Matrix metalloproteinase-2 activation modulates glioma cell migration","volume":"110","author":"Deryugina","year":"1997","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clineuro.2021.106771_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172234","article-title":"Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas","volume":"12","author":"Ramachandran","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clineuro.2021.106771_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0736-5748(99)00018-0","article-title":"Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas","volume":"17","author":"Vince","year":"1999","journal-title":"Int J. Dev. Neurosci."},{"key":"10.1016\/j.clineuro.2021.106771_bib16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.1993.378","article-title":"Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases","volume":"44","author":"Sorbi","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.clineuro.2021.106771_bib17","first-page":"1985","article-title":"Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases","volume":"15","author":"Nakagawa","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.clineuro.2021.106771_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.0305-1846.2000.00298.x","article-title":"Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro","volume":"27","author":"Rooprai","year":"2001","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.clineuro.2021.106771_bib19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1749-6632.1999.tb07753.x","article-title":"Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro","volume":"878","author":"Rooprai","year":"1999","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.clineuro.2021.106771_bib20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jgm.1473","article-title":"Group NCRRGW. Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"12","author":"Kilkenny","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.clineuro.2021.106771_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI57322","article-title":"Endothelial HIF-2alpha regulates murine pathological angiogenesis and revascularization processes","volume":"122","author":"Skuli","year":"2012","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.clineuro.2021.106771_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res Methods"},{"key":"10.1016\/j.clineuro.2021.106771_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-015-1998-4","article-title":"The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain","volume":"126","author":"Jackson","year":"2016","journal-title":"J. Neurooncol."},{"issue":"Suppl 2","key":"10.1016\/j.clineuro.2021.106771_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2131\/jts.6.SupplementII_189","article-title":"One month studies on the subacute toxicity of captopril in rats","volume":"6","author":"Imai","year":"1981","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.clineuro.2021.106771_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-018-2789-5","article-title":"Renin angiotensin system and its role in biomarkers and treatment in gliomas","volume":"138","author":"Perdomo-Pantoja","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1006421112839","article-title":"Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms","volume":"46","author":"Jaalinoja","year":"2000","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ene.12746","article-title":"Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma","volume":"22","author":"Januel","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106771_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11060-017-2528-3","article-title":"Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and\/or bevacizumab","volume":"134","author":"Levin","year":"2017","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1470320313496858","article-title":"The renin-angiotensin system meets the hallmarks of cancer","volume":"16","author":"Wegman-Ostrosky","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.clineuro.2021.106771_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.bjp.0704862","article-title":"Bradykinin potentiation by ACE inhibitors: a matter of metabolism","volume":"137","author":"Tom","year":"2002","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.clineuro.2021.106771_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2017.09.007","article-title":"Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels","volume":"410","author":"Zhang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.clineuro.2021.106771_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1012209518843","article-title":"Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta","volume":"53","author":"Wick","year":"2001","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2021.106771_bib33","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clineuro.2021.106771_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111199","article-title":"Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia","volume":"9","author":"Clarke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clineuro.2021.106771_bib35","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2217\/fon.14.175","article-title":"Radioprotective agents for radiation therapy: future trends","volume":"10","author":"Johnke","year":"2014","journal-title":"Future Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:40:06Z","timestamp":1759588806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"alternative-id":["S0303846721003000"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106771","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106771"}}